	Lifestyle-associated serum metabolites profiling in relation to risk of late-onset psoriasis. J Eur Acad Dermatol Venereol Zhou X, Wang Y, Pan Z, Chang Q, Zhu Y, Zhou G, Zhang G, Zhang Y, Chen X, Liu H. PMID: 40956048 [PubMed - as supplied by publisher]
	Can Week 4 PASI Response Serve as an Early Predictor of Apremilast Efficacy in Psoriasis? A Single-Centre Preliminary Study. Acta Derm Venereol Erol SN, Kartal SP. PMID: 40955533 [PubMed - in process]
	Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting. J Rheumatol Weiss PF, Ruperto N, Quebe-Fehling E, Shew A, Pricop L, Pieterse CC, Brunner HI, Paediatric Rheumatology INternational Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG) Investigative Sites. PMID: 40953957 [PubMed - as supplied by publisher]
	High persistence of biologic therapy in patients with Psoriatic arthritis: a real-world evidence from a high-complexity hospital in Colombia. Front Pharmacol Hormaza-Jaramillo A, Hurtado-Bermudez LJ, Peñaloza Gonzalez D, Delgado-Mora T. PMID: 40949147 [PubMed]
	Janus Kinase Inhibitors As Emerging Therapy in the Treatment of Psoriatic Arthritis: A Narrative Review of Efficacy, Safety, and Future Perspective. Cureus Barsoum M, Mohamed M, Ibrahim A, Khalfalla A, Elbashir L. PMID: 40949078 [PubMed]
	Skin immune microenvironment in psoriasis: from bench to bedside. Front Immunol Yao Y, Chen LQ, Lv YB, Tang SL, Shen W, Sun H, Zhong HJ. PMID: 40948748 [PubMed - indexed for MEDLINE]
	MAIT Cells with High PFN1 Expression Mediate Immune Activation and Metabolic Reprogramming in Psoriasis. Clin Cosmet Investig Dermatol Wu MN, Zou YM, Zhou XN, Hong S, Wang L, Bai YP. PMID: 40948612 [PubMed]
	Expression and Clinical Significance of Class â… Histone Deacetylases in the Serum of Patients With Psoriatic Arthritis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao Zhang MH, Dong WX, Wang J, Zhang GL. PMID: 40948260 [PubMed - indexed for MEDLINE]
	Establishing Consensus on Defining Failure of Topical Therapy in Psoriasis: Recommendations from the International Psoriasis Council. J Am Acad Dermatol Strober BE, Blauvelt A, Kerkhof PCMV, Asawanonda P, Chandra R, Gonzalez-Cantero A, Gonzalez C, Matlock BH, Maul JT, Rob F, Torres T, Skov L. PMID: 40945737 [PubMed - as supplied by publisher]
	Biologic-Induced Paradoxical Psoriatic Alopecia: A Systematic Review. Australas J Dermatol Gu Y, Sebaratnam DF, Makhija M, Farrell J. PMID: 40944329 [PubMed - as supplied by publisher]
	Systematic Literature Reviews on the Disease Burden of Pediatric Psoriasis. Dermatol Ther (Heidelb) Sanchez SZ, Tran T, Garcia A, Telukuntla V, Pillai S, Horgan J, Deignan C. PMID: 40938518 [PubMed - as supplied by publisher]
	Misfortunes never come alone: melanoma and ulcerative colitis after biologic therapy in a psoriatic patient - a case report and literature review. Front Immunol Bratborska AW, Ja, Bowszyc-Dmochowska M, Kowalczyk MJ, Adamska K. PMID: 40933992 [PubMed - indexed for MEDLINE]
	Effectiveness of Biologics on synovitis and enthesitis using Musculoskeletal ultrasound assessment in subclinical psoriatic arthritis: A 12-week observational real-world study. J Am Acad Dermatol Liu Z, Chen J, Zhou K, Gong T, Chen R, Xiao Z, Ke H, Xiao C, Lan J, Ji C, Xiang N. PMID: 40930421 [PubMed - as supplied by publisher]
	Global, Regional, and National Burden and Trends of Pediatric Psoriasis: Insights From the Global Burden of Disease Study 2021. Int J Dermatol Li X, Li W, Chen W, Liu H, Dong H, Li M, Li H. PMID: 40928123 [PubMed - as supplied by publisher]
	The Effect of Stigmatization on Working Nurses' Willingness to Care for Patients with Psoriasis and Its Mediating Factors. Acta Derm Venereol Kong S, Niu H, Xu X, Wang R, Cui S, Xie J, Zou W, Ye J, Kong D, Yao C, Yang H, Mi B, Geng S. PMID: 40928020 [PubMed - indexed for MEDLINE]
	Modest psoriasis risk from cardiometabolic progression: Genetics, patterns and limitations in a Biobank study. J Eur Acad Dermatol Venereol Chen SC, Tsai CF. PMID: 40927913 [PubMed - as supplied by publisher]
	Beyond the screen: exploring digital health experiences of individuals affected by psoriasis - a qualitative interview study. BMC Public Health Erbas ME, Ziehfreund S, Biedermann T, Zink A. PMID: 40926220 [PubMed - indexed for MEDLINE]
	Factors influencing the transition time from psoriasis to psoriatic arthritis: a real-world multicenter analysis. Rheumatol Int K, K, Tekeo, Sarg, Cengiz G, Balta NC, Alkan H, Kasman SA, , Orhan K, Gezer , Keskin D, Mülko, Re, Ataman , Bal A, Duruöz MT, Kücükakka, , Toprak M, Yurdakul OV, Meliko, Ayhan FF, Baykul M, Bodur H, Çal, Çapk, Devrimsel G, Hizmetli S, Kamanl, Keskin Y, Ecesoy H, Kutluk Ö, , Tolu S, Tuncer T, Özgöçmen S, Nas K. PMID: 40924166 [PubMed - indexed for MEDLINE]
	Guselkumab for Psoriasis in Patients With Active or Prior Malignancy: A Multicentre Retrospective Study. Australas J Dermatol Melgosa Ramos FJ, Alarcón SS, Puchades AM, Romero IB, Pastor GMP, Apetrei LS, Díaz FJM, Martorell A, Pastor MV, Salvador JMO, Torralba AS, Galarreta Pascual M, Magdaleno Tapial J. PMID: 40923243 [PubMed - indexed for MEDLINE]
	Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study. J Dermatol Takamura S, Saito S, Sugai S, Shiko Y, Yamaguchi T, Kawasaki Y, Fukuda T. PMID: 40922413 [PubMed - as supplied by publisher]

Articles 1 - 20 / 26573

Page 1 of 1329



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy